Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1034 of 1,261

  1. AR 065042

    DERIVADOS DE CINNOLINA, PROCESOS DE OBTENCION Y COMPOSICIONES FARMACEUTICAS

    ASTRAZENECA AB [SE] · Granted May 13, 2009 · Expires May 8, 2029

    granted

  2. US 7531556

    Compositions useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  3. US 7531536

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  4. US 7531500

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted May 12, 2009 · Expires May 7, 2029

    granted

  5. US 7531523

    Sodium channel protein type III alpha-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  6. US 7531341

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  7. US 7531514

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted May 12, 2009 · Expires May 7, 2029

    granted

  8. US 7531352

    Inducible plasmid vector encoding TGF-β and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  9. US 7531355

    Methods and compositions for smooth muscle reconstruction

    The Regents of the University of California · Granted May 12, 2009 · Expires May 7, 2029

    granted

  10. US 7531173

    Ophthalmic composition of a VEGF antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  11. US 7531172

    Methods of treating diseases with a VEGF antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  12. US 7531162

    Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation

    Regents of the University of Minnesota · Granted May 12, 2009 · Expires May 7, 2029

    granted

  13. US 7531635

    MATER-protein specific antibodies and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 12, 2009 · Expires May 7, 2029

    granted

  14. US 7531570

    Treatment of diseases using ICE inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  15. US 7531656

    Synthesis of gatifloxacin

    Teva Pharmaceuticals USA, Inc. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  16. US 7531623

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Theravance, Inc. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  17. US 7528138

    Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  18. US 7527786

    Methods for inhibiting the growth of cancer cells expressing PSCA

    The Regents of the University of California · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  19. US 7527802

    Vaccine for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  20. US 7527934

    Labeled substrate conjugates for identifying enzyme inhibitors

    The Regents of the University of California · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  21. US 7528202

    Poly (ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  22. US 7528253

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  23. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  24. US 7528142

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.